http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009129531-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55a20f90b04de598909a729c9dfebaec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f1f139f5b79ac5a43ee60615fb82e6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f07a9949329f4e2c071e326d6379be8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93289ad591ca005775b014f552586a2d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eeb75497a0e7ee663b0fa882fce73c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81a9ca61b3c21f5686cda31d39ced6f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553e0b69ade37fc28852d6f662589436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f0f8b09cbfa048257dfaa8f13bfb82
publicationDate 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009129531-A3
titleOfInvention Bupivacaine formulation in a polyorthoester carrier
abstract Effective treatments of pain, such as chronic pelvic pain, for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of bupivacaine formulated within a polyorthoester. By administration of one or more drug depots, one can relieve pain caused by diverse sources, including but not limited to chronic pelvic pain syndromes, spinal disc herniation ( i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least thirty days, at least sixty days, at least one hundred days or at least one hundred and thirty-five days.
priorityDate 2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005371-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03044076-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007133751-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128475943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413517

Total number of triples: 38.